BENLYSTA
The LUPUS community have received a good news yesterday.
BENLYSTA is the first drug for lupus to reach Phase 3 and achieve positive results, in the largest randomized placebo-controlled clinical trials ever completed in patients with SLE. Positive results from the first BENLYSTA trial, BLISS-52, were announced in July. The data represent an important milestone for the lupus community, which has not seen a new treatment for lupus approved by regulatory authorities in more than 50 years.
I am keeping my fingers crossed and fervently praying that Benlysta would finally be a successful drug for our lupus sufferer. And this point though I know it’s a long way to go, I am thanking God for this innovation.
Tags: lupus advocacy